| Authors: |
Martins C; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal. claudia.martins@i3s.up.pt.; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal. claudia.martins@i3s.up.pt., Mitchell MJ; Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Perelman School of Medicine, Penn Institute for RNA Innovation, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Perelman School of Medicine, Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Peer D; Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, 69978, Tel Aviv-Yafo, Israel.; Department of Materials Sciences and Engineering, Tel Aviv University, 69978, Tel Aviv-Yafo, Israel.; Center for Nanoscience and Nanotechnology, Tel Aviv University, 69978, Tel Aviv-Yafo, Israel.; Cancer Biology Research Center, Tel Aviv University, 69978, Tel Aviv-Yafo, Israel., Perrie Y; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., Siegwart DJ; Department of Biomedical Engineering, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.; Department of Biochemistry, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Alonso MJ; Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.; Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.; Madrid Institute for Advanced Studies in Nanoscience (IMDEA), 28049, Madrid, Spain. mariaj.alonso@usc.es., Aparicio-Blanco J; Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Plaza Ramón y Cajal, 28040, Madrid, Spain. juan.aparicio.blanco@ucm.es.; Institute of Industrial Pharmacy, Complutense University of Madrid, Madrid, Spain. juan.aparicio.blanco@ucm.es. |
